Health
Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study – News-Medical.Net
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has spread to over 58.8 million worldwide and caused over 1.3 million deaths. The rush to develop safe and effective vaccines to prevent the ongoing spread of SARS-CoV-2 is nearing the finish line as several promising candidates await regulatory body approval for widescale distribution and use.
A team of researchers from the USA and China have engineered a…
-
General18 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General20 hours agoPutin says US-Ukraine text could form basis for future peace agreement
-
General19 hours agoTroops critically injured in Washington shooting named as FBI launch terror probe
-
Business18 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors